Bria Barjuca, APRN
Family · Cincinnati, OHNPI 1023623808
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (47.4%), speaking fees and consulting fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Revance Therapeutics, Inc. at 49.5% of the total. 2025 is the largest year on record at $24,996, more than ten times the $983 reported in 2021. Among family clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,053 payments — averaging $35.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Revance Therapeutics, Inc.$19K
- AbbVie$4K
- Johnson & Johnson$2K
- Sun Pharmaceutical Industries Inc.$2K
- E.r. Squibb & Sons, L.L.C.$2K
- Lilly USA, LLC$1K
- plus $9K from 25 others
What the payments were for
- Consulting fees$1,1253%
- Speaking & faculty fees$17,12545%
- Travel & lodging$9503%
- Food & beverage$17,87247%
- Education$6112%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Revance Therapeutics, Inc. | 18 | $18,651 |
| AbbVie(2 entities) | 211 | $3,686 |
| Johnson & Johnson | 60 | $2,342 |
| Sun Pharmaceutical Industries Inc. | 87 | $1,763 |
| E.r. Squibb & Sons, L.L.C. | 78 | $1,503 |
| Lilly USA, LLC | 71 | $1,237 |
| Incyte Corporation | 87 | $1,204 |
| Sanofi | 47 | $1,091 |
| Regeneron Healthcare Solutions, Inc. | 38 | $884 |
| Pfizer | 55 | $757 |
| Novartis | 38 | $661 |
| Arcutis Biotherapeutics, Inc. | 76 | $626 |
| LEO Pharma Inc. | 29 | $561 |
| Dermavant Sciences, Inc. | 49 | $511 |
| UCB, Inc. | 27 | $458 |
| Galderma Laboratories, L.p. | 25 | $340 |
| Amgen | 10 | $288 |
| Almirall LLC | 12 | $240 |
| VYNE Pharmaceuticals Inc. | 7 | $219 |
| Janssen Scientific Affairs, LLC | 1 | $124 |
| Organon | 7 | $101 |
| Boehringer Ingelheim | 4 | $96 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $68 |
| Verrica Pharmaceuticals Inc. | 2 | $59 |
| Mayne Pharma Commercial LLC | 3 | $50 |
| EPI Health, LLC | 3 | $47 |
| Merz North America, Inc. | 1 | $28 |
| Stemline Therapeutics Inc. | 1 | $25 |
| LNHC, Inc | 1 | $23 |
| Botanix SB Inc | 1 | $22 |
| Journey Medical Corporation | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$37,684 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 36 | $172,285 |
| Dupixent SyringeDupilumab | 17 | $75,048 |
| Clobetasol Propionate | 167 | $7,105 |
| Fluorouracil | 76 | $6,212 |
| Tacrolimus | 39 | $4,849 |
| Ketoconazole | 202 | $2,660 |
| Gentamicin Sulfate | 49 | $2,008 |
| Calcipotriene | 16 | $1,879 |
| Triamcinolone Acetonide | 84 | $1,191 |
| Metronidazole | 18 | $1,013 |
| Minoxidil | 78 | $848 |
| ValacyclovirValacyclovir Hcl | 40 | $662 |
| Fluocinonide | 12 | $591 |
| Doxycycline Hyclate | 47 | $402 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 26 | $357 |
Paid to pharmacies, not to this prescriber.
Other family in Cincinnati
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Lindsey SpencerCincinnati$53K
- Jillian CowanCincinnati$20K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.